Key Insights

Highlights

Treatment Research

3 treatments under study, led by Azithromycin To Infants

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Active Not Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT03909737Phase 4Active Not RecruitingPrimary

Oral Azithromycin to Prevent Stillbirths and Infant Mortality in Mali

Showing all 1 trials

Research Network

Common Treatments

  • Azithromycin To Infants1
  • Azithromycin To Pregnant Women1
  • No Intervention To Pregnant Women1

Active Sponsors

  • University of Maryland, Baltimore1
  • Bill and Melinda Gates Foundation1

Top Investigators

Activity Timeline